Digital lifestyle intervention for lung cancer survivors
Effect of a Digital Lifestyle Intervention on Health-Related Quality of Life in Non-Small Cell Lung Cancer Survivors (QUALUCA): a Multicenter Randomized Controlled Trial
This study tests a mobile app that helps survivors of non-small cell lung cancer improve their health and well-being by encouraging exercise, healthy eating, and relaxation techniques.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 88 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Bern University of Applied Sciences Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 4 sites (Barmelweid and 3 other locations) |
| Trial ID | NCT05819346 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a mobile application designed to improve health-related quality of life (HRQoL) in survivors of non-small cell lung cancer (NSCLC). The intervention focuses on promoting physical activity, healthy nutrition, and breathing/relaxation exercises over a three-month period following treatment. The application was developed through a collaborative process involving software developers and potential users to ensure its relevance and usability. Participants will engage with the app to help manage symptoms and enhance their overall well-being post-treatment.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with non-small cell lung cancer and have recently completed treatment.
Not a fit: Patients who are unable to provide informed consent or have significant physical or cognitive limitations may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the quality of life for lung cancer survivors by addressing physical and psychological challenges.
How similar studies have performed: Other studies have shown promising results with lifestyle interventions for cancer survivors, indicating that this approach is both relevant and potentially effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Diagnosis of non-small cell lung cancer (NSCLC) * Estimated life expectancy of ≥ six months (judged by local investigators/responsible health professionals) * Undergoing inpatient or outpatient rehabilitation OR completion of planned surgery, chemotherapy, or radiation therapy for NSCLC within the past 24 weeks * Knowledge of German to understand study material and assessments * Access to a cell phone or tablet * Written informed consent Exclusion Criteria: * Inability to provide informed consent * Inability to participate in the intervention because of physical, cognitive, or safety reasons (judged by local investigators/responsible health professionals)
Where this trial is running
Barmelweid and 3 other locations
- Klinik Barmelweid AG — Barmelweid, Switzerland (Recruiting)
- Zürcher RehaZentren | Klinik Davos — Davos, Switzerland (Recruiting)
- Berner Reha Zentrum AG — Heiligenschwendi, Switzerland (Recruiting)
- Zürcher RehaZentren | Klinik Wald — Wald, Switzerland (Recruiting)
Study contacts
- Principal investigator: Anja Frei, PhD — University of Zurich
- Study coordinator: Anja Frei, PhD
- Email: anja.frei@uzh.ch
- Phone: +41 44 634 43 60
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.